A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: A Case Report

Hepatology. 2019 Oct;70(4):1477-1479. doi: 10.1002/hep.30659. Epub 2019 May 20.

Authors

Matthew J Stotts¹, Opaku Adjapong², David E Kaplan^{1

2}

Affiliations

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
² Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA.

PMID: 31004512
DOI: 10.1002/hep.30659

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Agents, Immunological / therapeutic use
Biopsy, Needle
Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / surgery
Drug Eruptions / etiology*
Drug Eruptions / therapy
Drug Substitution / methods
Follow-Up Studies
Hepatectomy / methods
Humans
Immunohistochemistry
Liver Neoplasms / drug therapy*
Liver Neoplasms / pathology
Liver Neoplasms / surgery
Male
Neoplasm Invasiveness / pathology
Neoplasm Staging
Nivolumab / adverse effects*
Nivolumab / therapeutic use
Phenylurea Compounds / therapeutic use
Phototherapy / methods
Prednisone / therapeutic use
Quinolines / therapeutic use
Treatment Outcome
Withholding Treatment

Substances

Antineoplastic Agents, Immunological
Phenylurea Compounds
Quinolines
Nivolumab
lenvatinib
Prednisone